Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas without effective therapeutics. Bioinformatics was used to identify potential therapeutic targets. Paired Box (PAX), Eyes Absent (EYA), Dachsund (DACH) and Sine Oculis (SIX) genes, which form a regulatory interactive network in Drosophila, were found to be dysregulated in human MPNST cell lines and solid tumors. We identified a decrease in DACH1 expression, and increases in the expressions of PAX6, EYA1, EYA2, EYA4, and SIX1-4 genes. Consistent with the observation that half of MPNSTs develop in neurofibromatosis type 1 (NF1) patients, subsequent to NF1 mutation, we found that exogenous expression of the NF1-GTPase activating protein-related domain normalized DACH1 expression. EYA4 mRNA was elevated more than 100-fold as estimated by quantitative real-time PCR in most MPNST cell lines. In vitro, suppression of EYA4 expression using short hairpin RNA reduced cell adhesion and migration and caused cellular necrosis without affecting cell proliferation or apoptotic cell death. MPNST cells expressing shEYA4 either failed to form tumors in nude mice or formed very small tumors, with extensive necrosis but similar levels of proliferation and apoptosis as control cells. Our findings identify a role of EYA4 and possibly interacting SIX and DACH proteins in MPNSTs and suggest the EYA4 pathway as a rational therapeutic target.
Introduction
Malignant peripheral nerve sheath tumors (MPNSTs) are highly aggressive soft tissue sarcomas with a poor prognosis. Half of MPNST cases arise in individuals with neurofibromatosis type 1 (NF1), an autosomal dominant disorder affecting approximately 1 in 3500 individuals worldwide (Friedman and Birch, 1997; Rasmussen and Friedman, 2000) . Although sporadic MPNSTs develop in the general population at the low incidence of 0.0001%, the lifetime risk of an NF1 patient developing MPNST is as high as 8-13% (Evans et al., 2002) . There is evidence suggesting that cells within plexiform neurofibromas, benign tumors found in B30% of NF1 patients, undergo malignant transformation and give rise to MPNST (Leroy et al., 2001; Ferner and Gutmann, 2002; Carroll and Ratner, 2008 ). MPNST remains a major source of mortality for NF1 patients, as there is currently no effective therapy. Conventional radiation and chemotherapy are generally unsuccessful in controlling MPNST growth, especially in NF1 patients. Although early detection and excision of the tumor improve survival, complete resection is not always feasible and local recurrence is common (Carli et al., 2005) . Metastasis to the lung, liver, and brain is also observed (Ferner and Gutmann, 2002) . Although the clinical course of NF1-associated MPNSTs is considerably worse than that of sporadic MPNSTs, their gene expression profiling is indistinguishable (Holtkamp et al., 2004; Watson et al., 2004; Miller et al., 2006) .
A major pathway implicated in MPNST formation is the NF1-Ras pathway. The NF1 gene product, neurofibromin, is one of a family of GTPase activating proteins (GAPs) that accelerates the hydrolysis of active Ras-GTP to inactive Ras-GDP (McCormick 1995) . Single missense mutations in the GAP-related domain (GRD) of NF1 have been detected in patients (Klose et al., 1998) . Furthermore, MPNST cell lines and tumors have elevated basal Ras-GTP (Basu et al., 1992; DeClue et al., 1992; Kim et al., 1995; Sherman et al., 2000) . Replacing the NF1-GRD rescued the cardiovascular defect responsible for embryonic lethality in NF1-deficient mice but did not rescue abnormalities in neural crest development (Ismat et al., 2006) , although several lines of evidence support the neural crest origin of NF1-associated MPNSTs (reviewed in Vogel et al., 1999; Carroll and Ratner, 2008; Miller et al., 2009) , suggesting involvement of additional or alternative molecular pathways in NF1 tumorigenesis.
To identify dysregulated molecular pathways in MPNSTs that might guide novel therapeutic strategies, we recently conducted global gene expression analysis of NF1-associated tumors and tumor-derived Schwann cells, including sporadic and NF1-derived MPNSTs, on the whole-genome Affymetrix platform (Santa Clara, CA, USA; Miller et al., 2009) . The mRNA encoding the SOX9 transcription factor was overexpressed in benign MPNST precursor lesions (neurofibroma), and expression of SOX9 was further elevated in MPNSTs. Computational promoter analysis identified Eyes Absent Homolog 4 (EYA4), a gene highly expressed in MPNSTs, as a potential transcriptional target of SOX9. Supporting the in silico analysis, inhibition of SOX9 expression using short hairpin RNA (shRNA) in MPNST cells reduced EYA4 expression levels, and exogenous expression of SOX9 in normal human Schwann cells (NHSCs) and neurofibroma cells increased EYA4 expression levels.
The transcriptional network involving members of the Eyes Absent (EYA), Sine Oculis (SIX), Dachsund (DACH), and Paired Box (PAX) gene families was originally characterized in fly eye development and is commonly referred to as the retinal determination (RD) pathway (Silver and Rebay, 2005) . Although the epistatic relationships among the ey-so-eya-dac genes in flies is well characterized, the expression relationships among the vertebrate Pax-Six-Eya-Dach genes differ based on tissue types and stages of development. The SIX proteins are DNA-binding transcription factors, which variously activate (Xu et al., 1996) or repress (Kobayashi et al., 2001; Zhu et al., 2002) transcription. The DACH proteins can also activate (Ikeda et al., 2002) or repress (Wu et al., 2006 (Wu et al., , 2009 transcription in a context-dependent manner. EYA proteins are both transcriptional activators (Xu et al., 1996) and tyrosine phosphatases (Rayapureddi et al., 2003; Tootle et al., 2003) and have recently been shown to dephosphorylate H2AX, promoting repair and cell survival in the response to DNA damage (Cook et al., 2009) . EYA proteins (EYA1-4) are normally expressed early in development (Xu et al., 1996; Abdelhak et al., 1997; Borsani et al., 1999) and promote stem cell survival (Li et al., 2003) . This is relevant, because mouse and human MPNST cells have characteristics of neural crest stem cells (Josephson et al., 1998; Vogel et al., 1999; Miller et al., 2009) .
Individual members of the RD pathway have been implicated in tumorigenesis . The expression of several PAX family members has been associated with cancer cell line survival (Muratovska et al., 2003) . Downregulation of DACH1 expression has been observed in breast (Wu et al., 2006) and prostate cancer (Wu et al., 2006 (Wu et al., , 2009 ).
Upregulation of SIX1 expression has been observed in a variety of cancers (Reichenberger et al., 2005; Ng et al., 2006; Behbakht et al., 2007; Kroemer et al., 2009) , and overexpression of SIX1 is sufficient for malignant transformation of mammary cells (Coletta et al., 2008) . Overexpression of EYA2 has been shown to promote ovarian tumor growth (Ramdas et al., 2001) . In this study, we describe the dysregulation of a transcriptional network consisting of the EYA, SIX, DACH and PAX genes in MPNSTs, and provide evidence supporting a role of EYA4 in MPNST survival and tumorigenesis.
Results
Expression of genes comprising the RD pathway is dysregulated in MPNST Global gene expression profiling in NF1-associated tumors and Schwann cells revealed a cluster of genes significantly overexpressed in MPNSTs relative to neurofibromas and normal Schwann cells (Miller et al., 2009) . A striking observation within this cluster is an upregulation in expression of EYA4 and one of its potential binding partners, SIX1. Expression profiles of EYA1, EYA2, EYA4 and SIX1-4 genes show differential expression of multiple family members in more than one MPNST sample relative to normal Schwann cells. Expression of PAX6 was also upregulated in all primary MPNSTs and 11 of 13 MPNST cell lines (Figure 1a) , and PAX6 is transcriptionally upstream of SIX and EYA in the RD pathway. Furthermore, expression of DACH1 was downregulated in MPNSTs ( Figure 1a) . Downregulation of DACH1 contrasts with upregulation in EYA1, EYA2, EYA4 and SIX1-4. DACH1 expression is lower than normal in most benign neurofibroma samples, as well as in MPNST samples. Expression levels of EYA4 and SIX1 are statistically different (analysis of variance; false discovery rate (FDR) ¼ 0.01) between benign neurofibromas and MPNSTs, and upregulated at least threefold in all MPNST samples ( Figure 1a) .
We confirmed the gene expression microarray data revealing differential expressions of PAX6, EYA, SIX1 and DACH1 in MPNSTs relative to NHSCs using quantitative real-time PCR (QRT-PCR) (Figures 1b-e) . The magnitude of the differential expression obtained using QRT-PCR was higher as compared with the microarray results, yet it showed the same trend. The QRT-PCR data corroborated the most robust overexpression in EYA4 (Figure 1c) , ranging from 50-fold to over 800-fold above NHSCs (13-fold to 67-fold for microarray data). The microarray expression data for DACH1 was somewhat variable in NHSCs (ranging from -3.7-to 3.2-fold relative to the mean), and one MPNST cell line, YST1, displayed overexpression of DACH1 (Figure 1a ). QRT-PCR results validated the microarray data, confirming reduced DACH1 expression in all MPNST cell lines, with the exception of YST1, relative to three independent NHSC samples ( Figure 1d ).
The NF1-GRD regulates the expression of DACH1 in MPNST cells The NF1-GRD is the best-characterized domain of NF1, converting activated Ras to its inactivated form. To observe transcriptional changes downstream of the NF1-GRD, we conducted gene expression microarray analysis on MPNST cells at 32 h after infection with an adenovirus encoding the NF1-GRD (relative to a green fluorescent protein (GFP) control) (Figure 2a ). This time point was chosen because it represents a significant EYA4 and MPNST tumorigenesis SJ Miller et al reduction in Ras-GTP, yet it is before cell death induced by exogenous expression of the NF1-GRD (data not shown). Forty-five genes were differentially expressed (X3-fold) in the MPNST 8814 cell line in response to the NF1-GRD expression (data not shown), including DACH1. Three of six DACH1 probe sets confirmed the decrease in expression in ST8814 MPNST cells relative to NHSCs that was not significantly changed by infection with a control adenoviral vector but increased significantly subsequent to infection with the NF1-GRD adenovirus. Failure to show this expression pattern with three DACH1 probe sets was likely due to probe set unreliability; note that the data in Figure 1 are shown with these unreliable probe sets removed as described (Daimaru et al., 1985) . Expressions of PAX, EYA and SIX genes were not significantly altered by NF1-GRD ( Figure 2a ), but DACH1 expression was increased to a level comparable with that of NHSCs ( Figure 2b ). Importantly, we confirmed that MPNST cells infected with the NF1-GRD adenovirus have significant reductions in Ras-GTP and downstream phospho-MEK and phospho-ERK protein levels at the 32-h time point (Figure 2c ). In addition, the significant increase in DACH1 expression by the NF1-GRD adenovirus was not observed with a GFP adenovirus control ( Figure 2d ). These results were confirmed by a time- Reducing EYA4 expression inhibits MPNST cell adhesion and migration To study the functional role of EYA4 in MPNST tumorigenesis, we first validated the microarray and QRT-PCR data by confirming elevated levels of EYA4 protein in MPNST cell lines relative to NHSCs at the protein level by western blotting. Two bands were observed in MPNST cell lines, likely representing the products of EYA4 transcript variants 1 and 2 (Borsani et al., 1999) , but not in NHSCs (Figure 3a) .
To observe the effects of reducing EYA4 expression in MPNST cells, S462TY MPNST cell lines stably expressing EYA4 shRNAs were created. We observed a marked decrease in EYA4 expression at the RNA level, as quantified by real-time PCR (Figure 3b) , and at the protein (Figure 3c ) level using four independent EYA4 shRNAs compared with the shRNA control. Similar results were obtained in two additional independent MPNST cell lines (data not shown). The extent of EYA4 knockdown varied from two-to ninefold and was stable, as the pattern of expression across clones was retained through several cell passages (passages 1-6).
To test the effect of reducing EYA4 on specific cellular mechanisms that regulate MPNST cell behavior, we conducted functional assays in vitro. The rounded appearance of cells expressing EYA4 shRNA several hours after plating and the lower number of cells remaining on plates after 4 days (Figure 3d ) suggested a defect in cell adhesion that was confirmed in a cell adhesion assay (Figure 3e ). When EYA4 expression was reduced in MPNST cells, a 60-95% reduction in migration was evident, and the extent of inhibition of migration correlated with extent of reduction in EYA4 expression (Figure 3f) . Thus, MPNST cell adhesion and motility are dependent on EYA4.
Reducing EYA4 expression induces MPNST cell death by necrosis An apparently slower growth rate was observed in culturing the MPNST-shEYA4 cells. A modest decrease in cell accumulation was evident, yet not significant, in a 9-day MTS assay (data not shown). Further investigation by fluorescence-activated cell sorting analysis confirmed no significant change in cell proliferation, apoptosis or cell cycle progression. (Figures 4a-f) . 5-Bromodeoxyuridine (BrdU) incorporation was used to confirm similar rates of proliferation in MPNSTshEYA4 and MPNST-shControl cells (data not shown). A similar small percentage of apoptotic cells were detected in both MPNST cells expressing shEYA4 and shControl (Figure 4g) , as confirmed by analysis of DNA fragmentation (data not shown).
As fewer cells were present in growth assays with undetectable differences in proliferation or apoptosis, we tested whether cell death by necrosis might account for the decrease in cell number. Necrotic cell death is associated with morphological changes, including cell shrinkage, cytosolic condensation, membrane morphology changes, loss of anchorage, and finally, cellular degradation (Krysko et al., 2008) . Evidence of cell death by necrosis was observed in live cultures of MPNSTshEYA4 cells by the robust uptake of propidium iodide (PI) due to extensive membrane damage. Only 4.3% of S462TY cells expressing a scramble shRNA were PI þ , whereas 15.0% of cells expressing EYA4.7 were PI þ (Krysko et al., 2008) . To validate this observation, we conducted flow cytometry. By flow cytometry, induction of cell death generally results in a shift of low side light scatter population to higher side light scatter population (Dive et al., 1992; Weston et al., 1994; Waring et al., 1999) . To prevent analysis confusions with possible artifacts from cell aggregates and debris in suspension, our analysis by flow cytometry focused on cell singlets from adherent cells. Despite carrying out the flow cytometry analysis in the adherent cell fraction, which is enriched in surviving cells, there was an B10% increase in light side scatter mean channel in cells expressing shEYA4 (Figure 4h ).
Reducing EYA4 expression inhibits MPNST formation in vivo in xenografts To determine whether EYA4 expression is critical for MPNST tumorigenesis, we tested the MPNST-shEYA4 cells in a mouse xenograft model using the S462TY cell line. By 60 days, MPNST cells expressing three independent EYA4 shRNAs showed significant reduction in tumor volumes (Figures 5a and b) . As in the in vitro cell migration studies described above (Figure 3f ), we observed a correlation with the levels of EYA4 and effects on tumor size. Expression levels of EYA4 in MPNST-shEYA4.5 and MPNST-shEYA4.7 were reduced greater than sixfold, and these cells did not develop detectable tumors; expression levels of EYA4 in MPNST-shEYA4.3 were reduced only twofold, and these cells developed small tumors by 60 days. Reduced expression of EYA4 was maintained in the MPNSTshEYA4.3 tumors relative to control tumors, as confirmed by QRT-PCR (Figure 5c ).
Histological analyses revealed significant areas of necrosis within the shEYA4-expressing tumors ( Figures  5e and g ). Similar degrees of proliferation and apoptosis in control and shEYA tumors were confirmed with Ki67 staining (Figures 5h and i) and TdT-mediated dUTP nick-end labeling assay (Figures 5j and k) , respectively. CD31 staining revealed similar vascularity (Figures 5l and m) .
Discussion
Microarray gene expression analysis revealed differential expressions of the members of RD transcriptional network, PAX6, EYA4, SIX1 and DACH1, in MPNSTs relative to NHSCs. The NF1-GRD induced DACH1 expression, implicating Ras signaling in the decreased DACH1 expression seen in MPNSTs. Expression of EYA4 was dramatically upregulated in MPNST cells and primary tumors, and inhibition of EYA4 expression using shRNA reduced MPNST cell adhesion and migration, and induced cell necrosis. Furthermore, tumorigenesis was profoundly inhibited when MPNST cells stably expressing shEYA4 RNA were injected into athymic nude mice, again correlating with necrosis. Our previous study (Miller et al., 2009) provided the evidence that overexpression of SOX9 is sufficient to induce EYA4 expression. We propose a model in which overexpression of SOX9 and loss of NF1 functions independently lead to dysregulation of the EYA4-SIX1-DACH1 transcription in MPNST.
The most dramatic differential expression was observed for EYA4, which was robustly overexpressed in all but one MPNST cell line and all primary MPNSTs, suggesting it and/or its family members may represent an MPNST oncogene. Its activity may be context specific, given other reports implicating EYA4 as a tumor-suppressor gene in gastrointestinal tumors (Zou et al., 2005; Osborn et al., 2006) . The expression pattern of PAX6, SIX1, EYA4 and DACH1 in MPNST cells suggests a scenario whereby the expression of multiple family members, and a tumorsuppressor role of DACH1 (Wu et al., 2006 (Wu et al., , 2008 (Wu et al., , 2009 ). However, the existence of a transcriptional network involving these genes has not been shown here and has not been definitively identified in mammalian cells. This study and our previous studies used expression differences between cultured Schwann cells and MPNST (Miller et al., 2006 (Miller et al., , 2009 . Gene expression changes are induced by cell isolation and tissue culture, and can interfere with the identification of relevant genes. In spite of these potential problems, our approach is supported by in vivo validation of the microarray data in solid tumors for EYA4, coupled with functional validation in xenografts for EYA4. Replacement of NF1-GRD in MPNST cells rescued DACH1 expression but did not alter the transcription of EYA4 and MPNST tumorigenesis SJ Miller et al EYA or SIX at 18-32 h, although we cannot exclude the possibility that at other time points or levels of GRD expression transcription of EYA or SIX might be changed. It is possible that a primary effect of the loss of NF1 on DACH1 secondarily affects transcription of the other members of the complex. Indeed, several lines of evidence support feedback activation of the network members on each other (O'Neill et al., 1994) . Furthermore, although only some neurofibroma samples have elevated SIX1 or EYA4 expression, DACH1 expression was low in many neurofibroma Schwann cell cultures and primary neurofibromas. Thus, our data support the idea that decreased DACH1 expression is an early event downstream of NF1 loss.
Eyes Absent Homolog 4 was upregulated in NF1-related and in sporadic MPNST cell lines, although Ras-GTP is not elevated in the same sporadic MPNST cells (Mahller et al., 2006) . In addition, EYA4 expression was not affected by replacing the NF1-GRD in NF1-deficient MPNST cells, suggesting NF1-Ras signaling does not regulate EYA4 expression. In Drosophila it has been shown that Ras signaling phosphorylates EYA proteins, increasing its transcriptional activity (Hsiao et al., 2001; Silver et al., 2003) . Thus, post-transcriptional regulation of EYA4 by the NF1-Ras pathway warrants future investigation. The mechanism(s) underlying high EYA4 expression in MPNST remain to be definitively determined but is likely to involve elevated SOX9 expression. SOX9 expression is elevated in both NF1-related and sporadic MPNST cell lines, and increasing SOX9 in wild-type Schwann cells is sufficient to increase EYA4 mRNA expression, whereas decreasing SOX9 mRNA levels in MPNST cells decreases EYA4 expression (Miller et al., 2009) .
Our results provide several lines of evidence supporting a role of EYA4 in cell survival, specifically in the inhibition of cell death by necrosis. Cell death is generally classified as either apoptosis or necrosis, a major distinction being the early breakdown of the plasma membrane in necrotic cells (Kroemer et al., 2009) . Molecular mechanisms regulating necrosis are not well understood; however, overactivation of poly (ADP-ribose) polymerase in response to extensive DNA damage results in depletion of ATP that can convert apoptosis to necrosis (Ha and Snyder, 1999) . The absence of changes in proliferation and apoptosis along with an increase in PI uptake suggested that necrosis may be the cause of decreased cell numbers in MPNST cells with reduced EYA4 expression. Further investigation in vitro supported necrotic cell death as increased side scatter was observed in fluorescenceactivated cell sorting analysis. In addition, tumors that developed in xenografts of MPNST cells with low levels of EYA4 showed significant areas of necrosis. In other systems, loss of EYA induces apoptosis (Cook et al., 2009) , suggesting the mechanism of cell death resulting from decreased EYA may depend on coregulatory factors. Our data also support a role of EYA4 in MPNST cell adhesion and migration, both of which are inhibited in response to reducing EYA4 expression. A reduction in cell adhesion can prompt anoikis; however, anoikis is usually associated with apoptosis rather than necrosis. Cellular changes downstream of EYA4, including cell adhesion, migration and survival, may reflect the metastatic behavior of MPNSTs (Klymkowsky and Savagner, 2009 ) and provoke further investigation.
We conclude that the NF1-Ras pathway can regulate the expression of DACH1, directly or indirectly, and EYA4 expression controls adhesion, migration and blocks necrosis in MPNST cells. Inhibition of EYA4 reduced tumorigenic properties of MPNST cells in vitro and resulted in MPNST cell death ex vivo, suggesting that developing therapeutics aimed at diminishing EYA4 expression or EYA4 transcriptional targets represented a strategy for killing MPNST cells.
Materials and methods

Microarray analyses
Collection of samples, RNA isolation, probe generation, Affymetrix HU133 Plus 2.0 microarray hybridization and normalization of data were conducted as described for differential gene expression in neurofibroma and MPNST samples relative to NHSCs (Miller et al., 2009) . Using Genespring GX v7.3.1 (Agilent Technologies, Santa Clara, CA, USA), hierarchical cluster analysis was conducted for all family members of the RD transcriptional network, and analysis of variance with a Benjamini and Hochberg FDR correction (FDR ¼ 0.01) was used to determine statistically significant changes in gene expression between NHSCs, neurofibroma samples and MPNST samples. For comparison of MPNST cells infected with adenovirus, gene expression was normalized to the average gene expression among three independent NHSC samples. Statistical analyses (analysis of variance; FDR ¼ 0.001) were used to identify significant gene expression changes between uninfected MPNST cells, MPNST cells infected with control (GFP) virus and MPNST cells infected with NF1-GRD virus.
Cell culture and tissue samples Normal human Schwann cells were cultured from trauma victims (Casella et al., 1996) and Schwann cells were cultured from dermal neurofibromas as described (Serra et al., 2000) . MPNST cell lines were cultured as described (Miller et al., 2006; Mahller et al., 2007) . NHSC, NHSCs; dNFSC, dermal neurofibroma Schwann cells; dNF, primary dermal neurofibromas; pNFSC, plexiforma neurofibroma Schwann cells; pNF, plexiform neurofibromas; MPNST, malignant peripheral nerve sheath tumor; MPNST cell lines include STS26T, ST8814, S462, S520, T265, .
Adenoviral infection
The NF1-GRD adenovirus was constructed by inserting a B1.1-kb Xba/HindIII fragment containing the coding sequence for the human NF1-GRD isoform I (GenBank NM_000267; (Viskochil and Carey, 1992 ) and a 5 0 -hemagglutinin (HA) tag into the pAdTrack vector (He et al., 1998) . The resulting vector, pAdTrack-NF1-GRD-HA, was linearized with PmeI and transformed into BJ5183 cells containing the pAdEasy vector. Recombinants were screened by restriction digestion, sequence verified and then transformed into DH5-a cells for amplification. Amplified clones were verified by HA expression and the ability to reduce Ras activity (see below).
For microarray and QRT-PCR experiments, MPNST cells were infected with an adenoviral construct expressing the NF1-GRD or GFP, in triplicate, with cesium-purified adenovirus for 2 h in serum-free medium at 200 plaque forming units per cell. Viruses were washed away and cells were cultured in normal medium for another 30 h, then RNA isolated as above was isolated for analysis of gene expression as described (Miller et al., 2009) .
Lentiviral infection
For lentiviral shRNA infection, MPNST cells at 70-90% confluence were infected with lentiviral particles containing shRNAs-targeting EYA4 (Open Biosystems, Huntsville, AL, USA, TRC library) or GFP (Addgene Inc., Cambridge, MA, USA). The Cincinnati Children's Hospital Medical Center (CCHMC) Viral Vector Core produced virus using a 4-plasmid packaging system (http://www.cincinnatichildrens. org/research/div/exp-hematology/translational/vpf/vvc/default. htm). Lentiviral particles were incubated with MPNST cells (multiplicity of infection B10) in the presence of polybrene (8 mg/ml; Sigma-Aldrich Corp., St Louis, MO, USA) for 24 h followed by selection in puromycin at a concentration (2 mg/ ml) that killed uninfected cells within 3 days.
QRT-PCR
Total RNA was isolated from cells using the RNeasy kit (Qiagen, Valencia, CA, USA) and used as a template for cDNA synthesis (Invitrogen Superscript II, Carlsbad, CA, USA) and QRT-PCR (ABI 7500 Sequence Detection System, Foster City, CA, USA) as described (Miller et al., 2006) .
Western blot analysis
Cell lysates were created and western blotting was carried out as described (Miller et al., 2006) . Membranes were probed with anti-EYA4 antibodies (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA; EYA4 (E-20): sc-15107), then, stripped and reprobed with anti-b-actin antibodies (Cell Signaling Technology, Inc., Danvers, MA, USA; #4967) as a loading control. Signals were detected using horseradish peroxidase-conjugated secondary antibodies (BioRad, Hercules, CA, USA) and the ECL Plus developing system (Amersham Biosciences, Piscataway, NJ, USA). ImageJ 1.33u software (http://rsb.info.nih.gov/ij/) was used to quantify EYA4 from scanned autoradiographs.
Ras activation assay
Ras activity was measured in MPNST cells as described (Mahller et al., 2006) . MPNST cell lines were infected with the NF1-GRD adenovirus or a vector encoding GFP. After 2 days , lysates were prepared and blotted directly for total canonical Ras proteins (H-, N-, K-Ras), active ERK or active MEK. Ras-GTP was evaluated by centrifuging beads conjugated with GST-Raf-RBD from cell lysates, and probing by western blots (Ras Activation Assay; Upstate Biotechnology, Billerica, MA, USA).
BrdU incorporation
At 24 h after plating 3 Â 10 4 MPNST cells onto glass coverslips, cells were labeled for 1 h with BrdU-labeling reagent, fixed in ethanol, and incubated with anti-BrdU antibodies followed by detection with fluorescein-conjugated secondary antibodies, according to the manufacturer's protocol (5-Bromo-2 0 -deoxy-uridine Labeling and Detection Kit II; Roche Applied Science, Indianapolis, IN, USA). All cell nuclei were labeled with PI (50 mg/ml). Total number of cells (PI þ ) and number of BrdU-positive cells were counted in five fields per sample and averaged.
Detection of apoptotic cells
Malignant peripheral nerve sheath tumor cells were plated in quadruplicate wells (2 Â 10 4 cells per well) of LabTek chamber slides (Nalge-Nunce International, Rochester, NY, USA), then infected with shEYA4 or shGFP lentiviral particles. After 3 days in the presence or absence of puromycin, cells were fixed for detection of DNA damage in apoptotic cells (Apo ssDNA kit; Cell Technology, Inc., Mountain View, CA, USA). Briefly, DNA was denatured, and single-stranded DNA (ssDNA) was detected with a primary anti-ssDNA antibody, followed by tetramethylrhodamine isothiocyanate (TRITC)-conjugated secondary antibodies. Five random fields in triplicate wells were counted, and TRITC-positive apoptotic cells were expressed as a percentage of total cells visualized by bisbenzimide staining of the nuclei.
Detection of necrotic cells
Live MPNST cells were incubated with PI (Sigma; 50 mg/ml) for 2 h at room temperature, 24 h after plating at a density of 50 000 cells per well in 35-mm dishes. Cells were photographed in seven randomly chosen fields per dish, in each of two dishes per condition. PI-positive cells (necrotic cells) were expressed as a percentage of total cells.
Migration assay
The migratory response of MPNST cells was measured using a modified Boyden chamber assay as described (Miller et al., 2006) . MPNST cells (4 Â 10 4 ) expressing shGFP or shEYA4 were plated in serum-free Dulbecco's modified Eagle's medium (DMEM) on the upper chamber of a transwell with 8 mm pores (Corning Inc., Corning, NY, USA). The lower chamber contained 800 ml DMEM plus serum. Cells were incubated for 16 h at 37 1C in 10% CO 2 . Nonmigrating cells were removed from the upper surface of the membrane with cotton swabs. Membranes were stained with bisbenzimide and mounted onto glass slides. Migration was quantified by counting cells in four fields. Each condition was performed in triplicate, and the number of migrated cells was normalized to the total number of cells on an unscraped filter to validate the total number of cells plated. Data shown are representative of three independent experiments; values presented are the mean ± s.d. Statistical significance was determined by t-test using Microsoft Excel software.
Mouse xenograft
Mouse xenografts of MPNST cells were conducted as described (Mahller et al., 2008) . A total of 1.2 Â 10 6 S462TY MPNST cells expressing shControl (n ¼ 10), shEYA4.3 (n ¼ 10), shEYA4.5 (n ¼ 10) or shEYA4.7 (n ¼ 10) were injected subcutaneously into 6-to 8-week-old female athymic nude (nu/nu) mice (Harlan, Indianapolis, IN, USA). Left and right flanks were injected with control or shEYA cells in each animal. In accordance with CCHMC rodent tumor guidelines, tumors may not exceed 10% of the body weight. Tumors formed in shControl cells in B30 days, reaching B2000 mm 3 in B60 days. Therefore, 59 days after injection, we measured tumor volume and euthanized all shControl mice and shEYA mice. Tumors were dissected and submitted to the CCHMC Pathology Laboratory for histological characterization, including hematoxylin-eosin staining, Mib-1 detection of proliferating cells, TdT-mediated dUTP nick-end labeling and detection of blood vessels using anti-CD31.
